Hadar Kolb - Search Results

Year	Number of Results
2013	1
2015	1
2016	3
2017	1
2018	1
2019	3
2021	2

1

Association of Chronic Active Multiple Sclerosis Lesions With Disability In Vivo.

Absinta M, Sati P, Masuzzo F, Nair G, Sethi V, Kolb H, Ohayon J, Wu T, Cortese ICM, Reich DS. Absinta M, et al. Among authors: kolb h. JAMA Neurol. 2019 Dec 1;76(12):1474-1483. doi: 10.1001/jamaneurol.2019.2399. JAMA Neurol. 2019. PMID: 31403674 Free PMC article.

2

Fingolimod Increases Brain-Derived Neurotrophic Factor Level Secretion from Circulating T Cells of Patients with Multiple Sclerosis.

Golan M, Mausner-Fainberg K, Ibrahim B, Benhamou M, Wilf-Yarkoni A, Kolb H, Regev K, Karni A. Golan M, et al. Among authors: kolb h. CNS Drugs. 2019 Dec;33(12):1229-1237. doi: 10.1007/s40263-019-00675-7. CNS Drugs. 2019. PMID: 31713782

3

Role of immunosuppressive therapy for the treatment of multiple sclerosis.

Stankiewicz JM, Kolb H, Karni A, Weiner HL. Stankiewicz JM, et al. Among authors: kolb h. Neurotherapeutics. 2013 Jan;10(1):77-88. doi: 10.1007/s13311-012-0172-3. Neurotherapeutics. 2013. PMID: 23271506 Free PMC article. Review.

4

A tri-modal distribution of age-of-onset in female patients with myasthenia gravis is associated with the gender-related clinical differences.

Asmail A, Kesler A, Kolb H, Drory VE, Karni A. Asmail A, et al. Among authors: kolb h. Int J Neurosci. 2019 Apr;129(4):313-319. doi: 10.1080/00207454.2018.1529669. Epub 2018 Oct 31. Int J Neurosci. 2019. PMID: 30260722

5

Characterization of patients with ocular myasthenia gravis - A case series.

Karni A, Asmail A, Drory VE, Kolb H, Kesler A. Karni A, et al. Among authors: kolb h. eNeurologicalSci. 2016 Apr 25;4:30-33. doi: 10.1016/j.ensci.2016.04.005. eCollection 2016 Sep. eNeurologicalSci. 2016. PMID: 29430546 Free PMC article.

6

Effect of ethnic origin and gender on the clinical manifestations of myasthenia gravis among the Jewish population in Israel.

Asmail A, Kesler A, Drory VE, Kolb H, Karni A. Asmail A, et al. Among authors: kolb h. J Neuroimmunol. 2017 Jun 15;307:47-52. doi: 10.1016/j.jneuroim.2017.04.003. Epub 2017 Apr 6. J Neuroimmunol. 2017. PMID: 28495138

7

Thymus involvement in myasthenia gravis: Epidemiological and clinical impacts of different self-tolerance breakdown mechanisms.

Karni A, Asmail A, Drory VE, Kolb H, Kesler A. Karni A, et al. Among authors: kolb h. J Neuroimmunol. 2016 Sep 15;298:58-62. doi: 10.1016/j.jneuroim.2016.07.002. Epub 2016 Jul 8. J Neuroimmunol. 2016. PMID: 27609276

8

Ultrahigh-resolution MRI Reveals Extensive Cortical Demyelination in a Nonhuman Primate Model of Multiple Sclerosis.

Donadieu M, Kelly H, Szczupak D, Lin JP, Song Y, Yen CCC, Ye FQ, Kolb H, Guy JR, Beck ES, Jacobson S, Silva AC, Sati P, Reich DS. Donadieu M, et al. Among authors: kolb h. Cereb Cortex. 2021 Jan 1;31(1):439-447. doi: 10.1093/cercor/bhaa235. Cereb Cortex. 2021. PMID: 32901254

9

Differential screening-selected gene aberrative in neuroblastoma (DAN) is increased in the CSF of patients with MS and may be induced by therapy with interferon-β.

Mausner-Fainberg K, Kolb H, Penn M, Regev K, Vaknin-Dembinsky A, Gadoth A, Kestenbaum M, Karni A. Mausner-Fainberg K, et al. Among authors: kolb h. J Neuroimmunol. 2016 Mar 15;292:93-6. doi: 10.1016/j.jneuroim.2016.01.019. Epub 2016 Jan 30. J Neuroimmunol. 2016. PMID: 26943965

10

Increased neutralization capacity of TNF-α in sera of relapsing remitting multiple sclerosis patients is not related to soluble TNF-α receptors or anti-TNF-α autoantibody levels.

Mausner-Fainberg K, Regev K, Kolb H, Vaknin-Dembinsky A, Karni A. Mausner-Fainberg K, et al. Among authors: kolb h. J Neuroimmunol. 2015 Sep 15;286:83-5. doi: 10.1016/j.jneuroim.2015.07.005. Epub 2015 Jul 17. J Neuroimmunol. 2015. PMID: 26298329

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results